| Pharmacological targeting of mitochondria in cancer stem cells: an ancient organelle at the crossroad of novel anti-cancer therapies J Skoda, K Borankova, PJ Jansson, MLH Huang, R Veselska, ... Pharmacological research 139, 298-313, 2019 | 77 | 2019 |
| Co-Expression of Cancer Stem Cell Markers Corresponds to a Pro-Tumorigenic Expression Profile in Pancreatic Adenocarcinoma J Skoda, M Hermanova, T Loja, P Nemec, J Neradil, P Karasek, ... PloS one 11 (7), e0159255, 2016 | 43 | 2016 |
| Repurposing Tyrosine Kinase Inhibitors to Overcome Multidrug Resistance in Cancer: A Focus on Transporters and Lysosomal Sequestration M Krchniakova, J Skoda, J Neradil, P Chlapek, R Veselska International Journal of Molecular Sciences 21 (9), 3157, 2020 | 42 | 2020 |
| CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines J Sana, I Zambo, J Skoda, J Neradil, P Chlapek, M Hermanova, P Mudry, ... Analytical Cellular Pathology 34 (6), 303-318, 2011 | 39 | 2011 |
| Cancer stem cell markers in pediatric sarcomas: Sox2 is associated with tumorigenicity in immunodeficient mice J Skoda, A Nunukova, T Loja, I Zambo, J Neradil, P Mudry, K Zitterbart, ... Tumor Biology 37 (7), 9535-9548, 2016 | 38 | 2016 |
| Tumour Microenvironment Stress Promotes the Development of Drug Resistance NA Seebacher, M Krchniakova, AE Stacy, J Skoda, PJ Jansson Antioxidants 10 (11), 1801, 2021 | 37 | 2021 |
| Expression of nestin, CD133 and ABCG2 in relation to the clinical outcome in pediatric sarcomas I Zambo, M Hermanova, D Zapletalova, J Skoda, P Mudry, M Kyr, ... Cancer Biomarkers 17 (1), 107-116, 2016 | 26 | 2016 |
| Cancer stem cells in sarcomas: Getting to the stemness core J Skoda, R Veselska Biochimica et Biophysica Acta (BBA)-General Subjects 1862 (10), 2134-2139, 2018 | 25 | 2018 |
| Atypical nuclear localization of CD133 plasma membrane glycoprotein in rhabdomyosarcoma cell lines A Nunukova, J Neradil, J Skoda, J Jaros, A Hampl, J Sterba, R Veselska International journal of molecular medicine 36 (1), 65-72, 2015 | 22 | 2015 |
| Detection of cancer stem cell markers in sarcomas R Veselska, J Skoda, J Neradil Klin Onkol 25 (Suppl 2), 2S16-2S20, 2012 | 18 | 2012 |
| Reduced ER–mitochondria connectivity promotes neuroblastoma multidrug resistance J Coku, DM Booth, J Skoda, MC Pedrotty, J Vogel, K Liu, A Vu, ... The EMBO Journal 41 (8), e108272, 2022 | 16 | 2022 |
| Serotonin limits generation of chromaffin cells during adrenal organ development P Kameneva, VI Melnikova, ME Kastriti, A Kurtova, E Kryukov, ... Nature Communications 13 (1), 1-21, 2022 | 14 | 2022 |
| Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology J Neradil, M Kyr, K Polaskova, L Kren, P Macigova, J Skoda, J Sterba, ... Frontiers in Oncology 9, 930, 2019 | 14 | 2019 |
| Noncanonical roles of p53 in cancer stemness and their implications in sarcomas L Curylova, H Ramos, L Saraiva, J Skoda Cancer letters 525, 131-145, 2022 | 13 | 2022 |
| EGFR signaling in the HGG-02 glioblastoma cell line with an unusual loss of EGFR gene copy J Skoda, J Neradil, K Zitterbart, J Sterba, R Veselska Oncology reports 31 (1), 480-487, 2014 | 11 | 2014 |
| NANOG/NANOGP8 Localizes at the Centrosome and is Spatiotemporally Associated with Centriole Maturation E Mikulenkova, J Neradil, O Vymazal, J Skoda, R Veselska Cells 9 (3), 692, 2020 | 10 | 2020 |
| Serial Xenotransplantation in NSG Mice Promotes a Hybrid Epithelial/Mesenchymal Gene Expression Signature and Stemness in Rhabdomyosarcoma Cells J Skoda, J Neradil, I Staniczkova Zambo, A Nunukova, P Macsek, ... Cancers 12 (1), 196, 2020 | 9 | 2020 |
| An unusual loss of EGFR gene copy in glioblastoma multiforme in a child: a case report and analysis of a successfully derived HGG-02 cell line R Veselska, J Skoda, T Loja, K Zitterbart, Z Pavelka, J Smardova, ... Child's Nervous System 26 (6), 841-846, 2010 | 6 | 2010 |
| Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms S Paukovcekova, J Skoda, J Neradil, E Mikulenkova, P Chlapek, J Sterba, ... Cancers 12 (12), 3781, 2020 | 5 | 2020 |
| Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors S Paukovcekova, M Krchniakova, P Chlapek, J Neradil, J Skoda, ... International Journal of Molecular Sciences 23 (15), 8549, 2022 | 4 | 2022 |
